John Burg

John has more than a decade of experience in protein biochemistry, structural biology and antibody discovery. At Pheast, John oversees research, data analysis, and project direction for the Protein Sciences team. Prior to joining Pheast, John led a team at Ligand Pharmaceuticals supporting antibody discovery, with a focus on antigen production and validation. Prior to Ligand, he served as Director of Biochemistry at Ab Initio Biotherapeutics, where he led protein biochemistry and molecular pharmacology efforts. John received his postdoctoral training at the Stanford University School of Medicine and his Ph.D. from the Johns Hopkins University School of Medicine.